LATEST NEWS

New LJI research could keep cancer-fighting T cells from burning out before the job is done
New A.P. Giannini Foundation Fellowship opens the door to an in-depth look at SARS-CoV-2 infections
LJI researchers highlight the importance of T cell cross reactivity in stopping severe COVID-19 cases
Adrian Enriquez, Ph.D., has a different way of looking at viruses
LJI scientists develop new tool for understanding enzymatic activity linked to blood cancers and heart disease
Treating patients with anti-CTLA4 therapies prior to anti-PD1 treatment may be a promising strategy
Throughout the pandemic, scientists in San Diego have made big contributions
The mission is simple: Figure out which key molecules go missing in cancer patients.
A curious researcher spots fascinating patterns in the lab and in life
New support from the American Cancer Society fuels research into the primary mutations behind many cancer types
National Cancer Institute support brings cancer researchers together to share key findings